InhibrxInc Valuation
| INBX Stock | USD 34.74 0.24 0.69% |
At this time, the firm appears to be undervalued. InhibrxInc retains a regular Real Value of $41.1 per share. The prevalent price of the firm is $34.74. Our model calculates the value of InhibrxInc from evaluating the firm fundamentals such as Return On Asset of -0.46, return on equity of -4.75, and Shares Outstanding of 47.39 M as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together. Key fundamental drivers impacting InhibrxInc's valuation include:
Price Book 38.1074 | Enterprise Value 1.6 B | Enterprise Value Ebitda (7.69) | Price Sales 920.9923 | Enterprise Value Revenue 883.336 |
Undervalued
Today
Please note that InhibrxInc's price fluctuation is very steady at this time. Calculation of the real value of InhibrxInc is based on 3 months time horizon. Increasing InhibrxInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for InhibrxInc is useful when determining the fair value of the InhibrxInc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of InhibrxInc. Since InhibrxInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InhibrxInc Stock. However, InhibrxInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 34.74 | Real 41.1 | Target 46.75 | Hype 34.74 | Naive 35.06 |
The real value of InhibrxInc Stock, also known as its intrinsic value, is the underlying worth of InhibrxInc Company, which is reflected in its stock price. It is based on InhibrxInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of InhibrxInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence InhibrxInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of InhibrxInc helps investors to forecast how InhibrxInc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InhibrxInc more accurately as focusing exclusively on InhibrxInc's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use InhibrxInc's intrinsic value based on its ongoing forecasts of InhibrxInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against InhibrxInc's closest peers. When choosing an evaluation method for InhibrxInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
InhibrxInc Investments |
|
InhibrxInc Valuation Trend
Knowing InhibrxInc's actual value is paramount for traders to make sound investment determinations. InhibrxInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of InhibrxInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both InhibrxInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
InhibrxInc Market Cap
InhibrxInc is rated fourth overall in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 18.12 Billion. InhibrxInc holds roughly 1.66 Billion in market capitalization claiming about 9% of equities under Health Care industry.InhibrxInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining InhibrxInc's current stock value. Our valuation model uses many indicators to compare InhibrxInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InhibrxInc competition to find correlations between indicators driving InhibrxInc's intrinsic value. More Info.InhibrxInc is currently regarded as number one stock in price to book category among related companies. It is rated fourth overall in price to sales category among related companies fabricating about 24.17 of Price To Sales per Price To Book. At this time, InhibrxInc's Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value InhibrxInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for InhibrxInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the InhibrxInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates InhibrxInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in InhibrxInc and how it compares across the competition.
About InhibrxInc Valuation
The stock valuation mechanism determines the current worth of InhibrxInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of InhibrxInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of InhibrxInc based exclusively on its fundamental and basic technical indicators. By analyzing InhibrxInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of InhibrxInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of InhibrxInc. We calculate exposure to InhibrxInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to InhibrxInc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 609 K | 639.5 K | |
| Pretax Profit Margin | (133.18) | (126.52) | |
| Operating Profit Margin | (121.79) | (115.70) | |
| Net Loss | (134.09) | (127.38) | |
| Gross Profit Margin | 0.34 | 0.36 |
8 Steps to conduct InhibrxInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates InhibrxInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct InhibrxInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain InhibrxInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine InhibrxInc's revenue streams: Identify InhibrxInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research InhibrxInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish InhibrxInc's growth potential: Evaluate InhibrxInc's management, business model, and growth potential.
- Determine InhibrxInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate InhibrxInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
InhibrxInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as InhibrxInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 47.1 M |
InhibrxInc Current Valuation Indicators
Valuation refers to the process of determining the present value of InhibrxInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value InhibrxInc we look at many different elements of the entity such as InhibrxInc's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. InhibrxInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final InhibrxInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as InhibrxInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use InhibrxInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes InhibrxInc's worth.When determining whether InhibrxInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of InhibrxInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inhibrxinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inhibrxinc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.